Dr. Nicole Shonka, MD
Claim this profileUniversity of Nebraska Medical Center
Studies Brain Tumor
Studies Glioblastoma
5 reported clinical trials
13 drugs studied
Area of expertise
1Brain Tumor
IDH positive
1p/19q co-deletion positive
SMO positive
2Glioblastoma
MET negative
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Nicole Shonka, MD is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting1 award Phase 210 criteria
APG-157 + Bevacizumab
for Brain Tumor
The goal of this interventional study is to evaluate the efficacy of APG-157 in combination with Bevacizumab in subjects with recurrent high-grade glioma. The main questions the study aims to answer are: * Progression-free and overall survival of patients receiving this combination; * Quality of Life (QOL); and * Tumor response on imaging The participants will take APG-157 daily by dissolving two pastilles in their mouth at around breakfast, lunch and dinner time (total of six pastilles per day). The pastilles dissolve in the mouth. The participants will continue to receive Bevacizumab as standard of care.
Recruiting1 award Phase 1 & 214 criteria
More about Nicole Shonka, MD
Clinical Trial Related10 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Nicole Shonka, MD has experience with
- APG-157
- Berubicin
- Lomustine
- Ipilimumab
- Nivolumab
- Radiation Therapy
Breakdown of trials Nicole Shonka, MD has run
Brain Tumor
Glioblastoma
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nicole Shonka, MD specialize in?
Nicole Shonka, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Nicole Shonka, MD currently recruiting for clinical trials?
Yes, Nicole Shonka, MD is currently recruiting for 2 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Nicole Shonka, MD has studied deeply?
Yes, Nicole Shonka, MD has studied treatments such as APG-157, Berubicin, Lomustine.
What is the best way to schedule an appointment with Nicole Shonka, MD?
Apply for one of the trials that Nicole Shonka, MD is conducting.
What is the office address of Nicole Shonka, MD?
The office of Nicole Shonka, MD is located at: University of Nebraska Medical Center, Omaha, Nebraska 68198 United States. This is the address for their practice at the University of Nebraska Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.